Your browser doesn't support javascript.
loading
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.
Araf, Shamzah; Wang, Jun; Korfi, Koorosh; Pangault, Celine; Kotsiou, Eleni; Rio-Machin, Ana; Rahim, Tahrima; Heward, James; Clear, Andrew; Iqbal, Sameena; Davies, Jeff K; Johnson, Peter; Calaminici, Maria; Montoto, Silvia; Auer, Rebecca; Chelala, Claude; Gribben, John G; Graham, Trevor A; Fest, Thierry; Fitzgibbon, Jude; Okosun, Jessica.
Afiliación
  • Araf S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. s.araf@qmul.ac.uk.
  • Wang J; Centre for Genomic Health, Queen Mary University of London, London, UK. s.araf@qmul.ac.uk.
  • Korfi K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Pangault C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Kotsiou E; UMR INSERM 1236, Université de Rennes, 1, EFS de Bretagne, CHU de Rennes, Rennes, France.
  • Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Rahim T; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Heward J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Clear A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Iqbal S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Davies JK; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Johnson P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Calaminici M; Cancer Sciences Unit, Cancer Research UK Centre, Southampton, UK.
  • Montoto S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Auer R; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Chelala C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Gribben JG; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Graham TA; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Fest T; Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Fitzgibbon J; UMR INSERM 1236, Université de Rennes, 1, EFS de Bretagne, CHU de Rennes, Rennes, France.
  • Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Leukemia ; 33(6): 1540, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30903015
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido